Alnylam Pharmaceuticals
ALNY
#1073
Rank
C$31.54 B
Marketcap
C$235.50
Share price
5.36%
Change (1 day)
-63.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company